The reaffirmation of a Buy rating and an $8 price target by a reputable analyst firm like HC Wainwright & Co. can instill confidence in investors and potentially lead to a positive short-term impact on Bolt Biotherapeutics' stock price. Analyst ratings, especially from well-regarded firms, often influence investor perception and can lead to stock price movements.